# Exploring infant gut–derived probiotics through 16S rRNA identification and in vitro functional characterization

**Authors:** Ishita Modasiya, Ritesh Nasit, Harsh Purohit, Apurba Kumar Sarkar, Vijay Kumar

PMC · DOI: 10.1371/journal.pone.0343741 · PLOS One · 2026-02-25

## TL;DR

This study identifies two probiotic bacteria from infant feces that show strong survival in the gut and antioxidant properties, suggesting potential for health supplements.

## Contribution

The study introduces two novel infant gut-derived probiotic strains with strong functional properties and safety profiles.

## Key findings

- Lb. paracasei IF5YR and Ent. faecium IF5RW2 showed high acid and bile tolerance, essential for gut survival.
- Both strains exhibited strong antioxidant activity and bile salt hydrolase activity, indicating functional benefits.
- Phylogenetic analysis confirmed the strains' taxonomic identities and safety through antibiotic susceptibility testing.

## Abstract

The infant gut microbiota significantly influences health outcomes, impacting digestion, immunity, and metabolic processes. Identifying beneficial microbes from this source offers promising avenues for novel probiotic development. This study aimed to identify and characterize potential probiotic bacterial isolates from infant fecal samples using 16S rRNA–based identification and in vitro experimental evaluations. A total of 47 isolates were initially screened. Two promising candidates, Lb. paracasei IF5YR and Ent. faecium IF5RW2, were selected and evaluated for gastrointestinal resilience (acid and bile tolerance), functional properties (autoaggregation, cell surface hydrophobicity, bile salt hydrolase activity, antioxidant activity via FRAP, ABTS, and DPPH assays), and safety (antibiotic susceptibility). Their genetic affiliations were confirmed using 16S rRNA sequencing, followed by bioinformatics and phylogenetic analyses. Both Lb. paracasei IF5YR and Ent. faecium IF5RW2 demonstrated strong acid (pH 1.5) and bile (2%) tolerance, high autoaggregation (>70%), and notable cell surface hydrophobicity (>90% for xylene). Comparative analysis of antibiotic susceptibility confirmed their safety. Phylogenetic analysis based on 16S rRNA sequencing supported the taxonomic affiliation of the isolates. Functionally, both strains exhibited bile salt hydrolase activity and strong antioxidant potential, with FRAP values exceeding 75%. These findings suggest Lb. paracasei IF5YR and Ent. faecium IF5RW2 may be considered potential candidates for probiotic applications related to gut health and oxidative stress modulation. They hold potential for development as novel functional food ingredients or health-promoting supplements, although in vivo or clinical studies are needed to confirm any therapeutic effects.

## Linked entities

- **Chemicals:** ABTS (PubChem CID 35688)

## Full-text entities

- **Genes:** CAT (catalase) [NCBI Gene 847]
- **Diseases:** lactose intolerance (MESH:D007787), Haemolytic (MESH:D006463), metabolic (MESH:D008659), haemolysis (MESH:D006461), inflammatory (MESH:D007249), gut dysbiosis (MESH:D064806)
- **Chemicals:** TPTZ (MESH:C002849), AMP (MESH:D000667), ABTS (MESH:C002502), acetate (MESH:D000085), CHL (MESH:D002701), bile salt (MESH:D001647), Azino-Bis (3-Ethyl-Benzothiazoline) 6-Sulfonic Acid (-), TET (MESH:D013752), penicillin (MESH:D010406), toluene (MESH:D014050), hydrocarbon (MESH:D006838), potassium persulfate (MESH:C009007), water (MESH:D014867), sodium taurocholate (MESH:D013656), vancomycin (MESH:D014640), HCl (MESH:D006851), Ascorbic acid (MESH:D001205), CaCl2 (MESH:D002122), ERY (MESH:D004917), cholesterol (MESH:D002784), sodium deoxycholate (MESH:D003840), methanol (MESH:D000432), phosphate (MESH:D010710), xylene (MESH:D014992), Ferrous sulphate (MESH:C020748), STR (MESH:D013307), agar (MESH:D000362), FeCl3 (MESH:C024555), CIP (MESH:D002939), 2, 2-Diphenyl-1-Picrylhydrazyl (MESH:C004931)
- **Species:** Limosilactobacillus fermentum (species) [taxon 1613], Enterococcus faecium (species) [taxon 1352], Lactiplantibacillus plantarum (species) [taxon 1590], Lacticaseibacillus casei (species) [taxon 1582], Homo sapiens (human, species) [taxon 9606], Bifidobacterium (genus) [taxon 1678], Lactiplantibacillus plantarum subsp. plantarum (subspecies) [taxon 337330], Lactobacillus delbrueckii (species) [taxon 1584], Lactobacillus delbrueckii subsp. delbrueckii (subspecies) [taxon 83684], Lacticaseibacillus paracasei (species) [taxon 1597], Lactobacillus delbrueckii subsp. lactis (subspecies) [taxon 29397], Lactiplantibacillus pentosus (species) [taxon 1589], Enterococcus durans (species) [taxon 53345], Lacticaseibacillus rhamnosus (species) [taxon 47715]
- **Cell lines:** IF5YR — Homo sapiens (Human), Lung small cell carcinoma, Cancer cell line (CVCL_0C32)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935197/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935197/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935197/full.md

---
Source: https://tomesphere.com/paper/PMC12935197